Christine Brennan
Direttore/Membro del Consiglio presso BOUNDLESS BIO, INC.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Hong I. Wan | M | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | - |
| Peter Dudek | M | - |
Merck Research Ventures
 Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts.
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | 6 anni |
| Zachary Hornby | M | 45 | 5 anni | |
| Daniel Burgess | M | 62 |
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | 5 anni |
| Kazumi Shiosaki | M | 69 |
Redona Therapeutics, Inc.
 Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | - |
| Teri F. Willey | F | - |
Pathway To Cures
 Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | 2 anni |
| Jonathan Lim | M | 52 | 6 anni | |
| Edward Darr | M | - |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | - |
| Leonard Valentino | M | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | - |
| Brian Andrew | M | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | 1 anni |
| Kristina Burow | F | 50 | 5 anni | |
| Geeta S. Vemuri | M | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | 1 anni |
| Jaume Pons | M | 58 |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | - |
| Michal Silverberg | F | 48 |
Novartis Venture Funds (USA)
 Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | 7 anni |
| Isaac Cheng | M | - |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | - |
| Haiyan Jiang | F | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | - |
| Nancy Whiting | M | 51 | 1 anni | |
| Sara Weymer | F | - | 2 anni | |
| Katherine High | F | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | - |
| Danilchanka Olga | M | - |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | 6 anni |
| Glenn Pierce | M | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | - |
| Steven Pipe | M | - |
Pathway To Cures
Pathway To Cures Investment ManagersFinance Pathway To Cures (Pathway To Cures) is a venture capital firm founded in 2022. The firm is headquartered in New York. | - |
| Kleem Chaudhary | M | 48 |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | - |
| Luke Evnin | M | 60 |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | - |
| Sahil Chopra | M | - |
Vertex Ventures HC
 Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 1 anni |
| David Morris | M | - |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 8 anni |
| Lori Hu | F | 38 |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 9 anni |
| Sandeep Bhadra | M | - |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 7 anni |
| Dave van Meter | M | - |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 1 anni |
| Henrijette Richter | M | 53 |
Redona Therapeutics, Inc.
Redona Therapeutics, Inc. BiotechnologyHealth Technology Redona Therapeutics, Inc.operates as a biotechnology company focused on the modulation of non- RNA (ncRNA) function to treat cancer and other human diseases. It uses small molecules to modulate expression levels of oncogenes and other proteins of significance in disease. The company was founded by George Daley, Richard Gregory, Frank Slack, and Piotr Sliz and is headquartered in Watertown, MA. | 5 anni |
| Jennifer Lew | F | 51 | 2 anni | |
| Aaron B. Margolin | M | - |
University of New Hampshire
| 34 anni |
| George Golumbeski | M | 67 |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | - |
| Corey Goodman | M | 72 |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. BiotechnologyHealth Technology Tallac Therapeutics, Inc. engages in the development of immunomodulating polynucleotides. The company is headquartered in Burlingame, CA. | - |
| Faheem Hasnain | M | 65 |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | - |
| Jamie Christensen, PhD | - | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Dana E. Putnam | M | - |
University of New Hampshire
| 6 anni |
| Fabio Pucci | M | 39 | - | |
| Manwar Hossain | M | 54 |
University of New Hampshire
| 4 anni |
| Patrick J. Sweeney | M | - |
University of New Hampshire
| 4 anni |
| Benjamin Cravatt | M | 54 | 5 anni | |
| Geoffrey F. Ide | M | 70 |
University of New Hampshire
| 2 anni |
| Robert Costello | M | - |
University of New Hampshire
| 4 anni |
| Celina Adams | F | - |
University of New Hampshire
| 1 anni |
| Jennifer Bruno | F | - |
University of New Hampshire
| 4 anni |
| Saud Abdulaziz Ahmad Al-Ayoub | M | - |
University of New Hampshire
| 4 anni |
| Alison Goldwater | F | - |
University of New Hampshire
| 4 anni |
| Samuel R. Hawley | M | - |
University of New Hampshire
| 4 anni |
| James A. Therriault | M | 63 |
University of New Hampshire
| 2 anni |
| Chris Jensen | M | - |
University of New Hampshire
| 5 anni |
| Nancy A. Kellerman | F | - |
University of New Hampshire
| 4 anni |
| Jeffrey Barlow | M | - |
University of New Hampshire
| 4 anni |
| Arthur Tzianabos | M | 60 |
University of New Hampshire
| 4 anni |
| Steven B. Girard | M | - |
University of New Hampshire
| 4 anni |
| David Cyr | M | - |
University of New Hampshire
| 4 anni |
| Jeff Hare | M | - |
University of New Hampshire
| 4 anni |
| Gary M. Cowles | M | - |
University of New Hampshire
| 4 anni |
| Reza Halse | M | 50 |
Merck Research Ventures
Merck Research Ventures Investment ManagersFinance Merck Research Ventures (Merck Research) is a venture capital subsidiary of Merck Research Laboratories Massachusetts LLC founded in 2000. The firm is headquartered in Cambridge, Massachusetts. | 4 anni |
| Lee-Ann Perkins | M | - |
University of New Hampshire
| - |
| Wendy Mahmouzian | F | - |
University of New Hampshire
| 3 anni |
| Shawn Fu | M | - |
Vertex Ventures HC
Vertex Ventures HC Investment ManagersFinance Vertex Ventures HC (Vertex Ventures) is a venture capital subsidiary of Vertex Venture Holdings Ltd founded in 2014. The firm is headquartered in San Francisco, California. | 5 anni |
| Dan Demers | M | - |
University of New Hampshire
| 4 anni |
| Gang Wang | M | 67 |
Dartmouth Medical School
| 3 anni |
| David Bacon | M | 57 |
University of New Hampshire
| 4 anni |
| Laurie Doran | F | - |
University of New Hampshire
| 4 anni |
| David Cooper | M | - |
University of New Hampshire
| 5 anni |
| Kent John | M | - |
University of New Hampshire
| 4 anni |
| Lisa LaBonville | F | 52 |
University of New Hampshire
| 4 anni |
| Joel Mittelman | M | - |
University of New Hampshire
| 4 anni |
| Dave Beaulieu | M | - |
University of New Hampshire
| 3 anni |
| Mark I. Robinson | M | - |
University of New Hampshire
| 4 anni |
| James Tananbaum | M | 60 | - | |
| Praveen Tyle | M | 64 |
Biovail Corp.
 Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 1 anni |
| Dana Hilt | M | 71 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | - |
| Stacey Stevens | F | 56 |
University of New Hampshire
| - |
| Mary Garceau | F | 51 |
University of New Hampshire
| 4 anni |
| Scott Dresser | M | 57 |
University of New Hampshire
| 4 anni |
| Kyle F. Frey | M | - |
University of New Hampshire
| 4 anni |
| Alex Ely | M | 54 |
University of New Hampshire
| 4 anni |
| Thomas A. Cloutier | M | - |
University of New Hampshire
| 4 anni |
| Mark Leslie | M | - |
University of New Hampshire
| 4 anni |
| Maureen Pettirossi | F | - |
University of New Hampshire
| 4 anni |
| Jeffrey Douglas Lent | M | - |
University of New Hampshire
| 4 anni |
| Jeffrey D. Storey | M | 58 |
Dartmouth Medical School
| 3 anni |
| Bradley T. Miller | M | 61 |
University of New Hampshire
| 2 anni |
| Brian T. O'Connor | M | - |
University of New Hampshire
| 4 anni |
| Kermit Hoffman | M | - |
University of New Hampshire
| 4 anni |
| Rajiv Sudhir Parikh | M | - |
University of New Hampshire
| 4 anni |
| Mark Durham | M | - |
Biovail Corp.
Biovail Corp. Pharmaceuticals: MajorHealth Technology Biovail Corp. develops and manufactures pharmaceutical products. The company provides different types of products which include Wellbutrin SR, Retavase, Zyban and Tiazac XC in Canada and Zovirax Ointment and Zovirax Cream in the United States. Its products are used for cardiovascular disease, central nervous system disorders, pain management and other niche areas. It was founded on March 29, 1994 and is headquartered in Mississauga, Canada. | 7 anni |
| Colleen Hansen | F | - |
University of New Hampshire
| 4 anni |
| Scott Sorensen | M | - |
University of New Hampshire
| 4 anni |
| Steven M. Hutchins | M | - |
University of New Hampshire
| 4 anni |
| Rich Ashooh | M | - |
University of New Hampshire
| 4 anni |
| Joseph Reilly | M | 67 |
University of New Hampshire
| 2 anni |
| Daniel S. Mirman | M | 52 |
University of New Hampshire
| 4 anni |
| Brian M. Quirk | M | - |
University of New Hampshire
| 4 anni |
| Michael A. Nickerson | M | - |
University of New Hampshire
| 4 anni |
| Lauren Silverman | M | 69 |
Novartis Venture Funds (USA)
Novartis Venture Funds (USA) Investment ManagersFinance Founded in 1996, Novartis Venture Funds (USA) is a venture capital firm located in Cambridge, Massachusetts. The firm is a subsidiary of Switzerland-based Novartis Venture Funds and their ultimate parent is Novartis AG, a Switzerland-based company that engages in the research, development, manufacturing and marketing of healthcare products. Novartis Venture Funds manages the Bermuda domiciled biotechnology venture fund, Novartis BioVentures Ltd | 10 anni |
| Jeffrey Stavenhagen | M | - |
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 97 | 97.98% |
| Canada | 2 | 2.02% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Christine Brennan
- Contatti personali
